Clinical Trials
MC2 Therapeutics A/S Announces First Patient Dosed in Pivotal US Phase 3 Trial in Psoriasis Vulgaris
MC2 Therapeutics A/S, a clinical-stage dermatology and eye care company today announced that first patient has been dosed in its pivotal Phase 3 clinical...
Industry Reports
CE Marking for World’s Only Integrated HIV Self-Test from Atomo Diagnostics Gives Access to Safe, Accurate and Reliable Self-Testing
Atomo Diagnostics, a world leader in innovative point-of-care, rapid diagnostic devices, announced today that its Atomo HIV Self Test has been granted CE Marking...
News
Kaleido Biosciences and CoreBiome Partner to Accelerate Microbiome Therapeutic Development
Kaleido Biosciences, a clinical-stage biotechnology company developing novel chemistries to unlock the power of the human microbiome, today announced an agreement with CoreBiome, a...
Press Releases
KalVista Pharmaceuticals Announces Collaboration with Merck
KalVista Pharmaceuticals, Inc , a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors announced that it...
Clinical Trials
OncoArendi Therapeutics to Begin the Phase 1 Clinical Evaluation of its Novel Class of Medicines
OncoArendi Therapeutics announced today that this week the Company will initiate a Phase 1 study designed to assess the safety, tolerability and pharmacokinetics of...
News
Heptares founder richard henderson receives nobel prize in chemistry 2017 for pioneering work in cryo-em for visualising biological structures
Heptares Therapeutics (“Heptares”), a wholly owned subsidiary of Sosei Group Corporation (“Sosei”; TSE Mothers Index: 4565), is delighted that one of its founders, Richard...
Packaging & Labelling
Market launch: new filling and closing machine AFG 5000 from Bosch
As part of an exclusive machine presentation in Crailsheim from September 18 through 29, 2017, Bosch Packaging Technology introduced the latest addition to its...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
